-
Je něco špatně v tomto záznamu ?
Stability of ramipril in the solvents of different pH
Hanysová L, Václavková M, Dohnal J, Klimes J.
Jazyk angličtina Země Velká Británie
- MeSH
- koncentrace vodíkových iontů MeSH
- ramipril analýza chemie MeSH
- rozpouštědla analýza chemie MeSH
- stabilita léku MeSH
- vysokoúčinná kapalinová chromatografie metody MeSH
The stability of ramipril in the buffer solution with different pH and the influence of acid, alkaline and oxidative medium on ramipril stability were studied. The ramipril degradation products were determined by high-performance liquid chromatography (HPLC) method. Acetonitrile:sodium perchlorate was used as the mobile phase, at a flow rate of 1.0 ml/min (linear gradient elution). A Nucleosil 100-S 5 microm C18, 250 mm x 4.6 mm i.d. was utilized as stationary phase. Detection was affected spectrophotometrically at 210 nm. The drug substance was dissolved in the ammonium phosphate buffer (pH 3, 5 and 8) and these solutions were stored at 90 degrees C for 1 h. The other series of test solutions were prepared from stock solution (drug substance dissolved in solvent A of the mobile phase) by dilution in acid (0.1M HCl), alkaline (0.1M NaOH) and oxidative (hydrogen peroxide solution) medium. More then 0.2% of impurity D (ramipril-diketopiperazine) was detected in the buffer of pH 3 and pH 5. In the buffer of pH 8 there was detected more then 1% of impurity E (ramipril-diacid). No peaks for degradation products appeared in the chromatograms above limit of quantification. The alkaline medium has the greatest effect on degradation of ramipril into impurity E (more than 50%).
Citace poskytuje Crossref.org
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07520441
- 003
- CZ-PrNML
- 005
- 20111210131126.0
- 008
- 090402s2005 xxk e eng||
- 009
- AR
- 024 __
- $a 10.1016/j.jpba.2004.10.041 $2 doi
- 035 __
- $a (PubMed)15862704
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Hanyšová, L.
- 245 10
- $a Stability of ramipril in the solvents of different pH / $c Hanysová L, Václavková M, Dohnal J, Klimes J.
- 314 __
- $a Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. polasek@faf.cuni.cz
- 520 9_
- $a The stability of ramipril in the buffer solution with different pH and the influence of acid, alkaline and oxidative medium on ramipril stability were studied. The ramipril degradation products were determined by high-performance liquid chromatography (HPLC) method. Acetonitrile:sodium perchlorate was used as the mobile phase, at a flow rate of 1.0 ml/min (linear gradient elution). A Nucleosil 100-S 5 microm C18, 250 mm x 4.6 mm i.d. was utilized as stationary phase. Detection was affected spectrophotometrically at 210 nm. The drug substance was dissolved in the ammonium phosphate buffer (pH 3, 5 and 8) and these solutions were stored at 90 degrees C for 1 h. The other series of test solutions were prepared from stock solution (drug substance dissolved in solvent A of the mobile phase) by dilution in acid (0.1M HCl), alkaline (0.1M NaOH) and oxidative (hydrogen peroxide solution) medium. More then 0.2% of impurity D (ramipril-diketopiperazine) was detected in the buffer of pH 3 and pH 5. In the buffer of pH 8 there was detected more then 1% of impurity E (ramipril-diacid). No peaks for degradation products appeared in the chromatograms above limit of quantification. The alkaline medium has the greatest effect on degradation of ramipril into impurity E (more than 50%).
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
- 650 _2
- $a stabilita léku $7 D004355
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a ramipril $x analýza $x chemie $7 D017257
- 650 _2
- $a rozpouštědla $x analýza $x chemie $7 D012997
- 700 1_
- $a Václavková, M.
- 700 1_
- $a Dohnal, J.
- 700 1_
- $a Klimeš, Jiří, $d 1950- $7 jn20000710203
- 773 0_
- $w MED00002894 $t Journal of pharmaceutical and biomedical analysis $g Roč. 37, č. 5 (2005), s. 1179-1183 $x 0731-7085
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090310084605 $b ABA008
- 991 __
- $a 20090621161710 $b ABA008
- 999 __
- $a ok $b bmc $g 638244 $s 491043
- BAS __
- $a 3
- BMC __
- $a 2005 $b 37 $c 5 $d 1179-1183 $i 0731-7085 $m Journal of pharmaceutical and biomedical analysis $x MED00002894
- LZP __
- $a 2009-B2/ipme